Risk Factors and Complications Among Pediatric Patients With Sickle Cell Anemia: A Single Tertiary Center

Fatma Alzahrani1, Anas M Fallatah2, Fatimah M Al-Haddad3

  • 1Pediatrics, King Abdulaziz University Hospital, Jeddah, SAU.

Cureus
|February 8, 2021
PubMed

Insights

Pediatric sickle cell anemia patients with high white blood cell counts, elevated systolic blood pressure, and hypoxia face increased risks of complications. Early identification and management of these factors are crucial for improving patient outcomes and quality of life.

Area of Science:

  • Pediatrics
  • Hematology
  • Genetics

Background:

  • Sickle cell anemia (SCA) is a prevalent genetic disorder in Saudi Arabia, causing red blood cell malformation and leading to severe systemic complications.
  • These complications, including vaso-occlusive crisis (VOC) and stroke, are the primary drivers of mortality in SCA patients.
  • Understanding risk factors for SCA complications is vital for reducing mortality and enhancing patient quality of life.

Purpose of the Study:

  • To identify risk factors associated with SCA complications in pediatric patients.
  • To investigate the relationship between clinical parameters and the occurrence of complications in children with SCA.

Main Methods:

  • A retrospective study was conducted from January 2012 to June 2019 at King Abdulaziz University Hospital, Jeddah, KSA.
  • Data were collected from electronic medical records of 102 pediatric SCA patients, excluding those with thalassemia or other chronic diseases.
  • Statistical analysis was performed to determine significant risk factors for SCA complications.

Main Results:

  • Urinary tract infection (UTI) and vaso-occlusive crisis (VOC) were the most frequent complications, followed by acute chest syndrome (ACS) and stroke.
  • While HbSS genotype was common, no significant association was found between genotype and complication development.
  • High white blood cell (WBC) counts, elevated systolic blood pressure (SBP), and hypoxia were significantly linked to an increased incidence of complications (p<0.05).

Conclusions:

  • Pediatric patients with SCA exhibiting high WBC counts, elevated SBP, and hypoxia are at a higher risk of developing complications.
  • Healthcare providers should implement measures to mitigate these risks, including patient/family education on risk factors, immunizations, and precautionary strategies.
  • Proactive management of identified risk factors can significantly improve the quality of life for children with sickle cell anemia.

Related Concept Videos

Hemodialysis II: Procedure and Complications01:24

Hemodialysis II: Procedure and Complications

DialyzersA hemodialysis (HD) dialyzer is a plastic cartridge containing thousands of parallel hollow fibers, which serve as semipermeable membranes. These fibers are typically made from cellulose-based or other synthetic materials. During HD, blood is pumped into the top of the cartridge and distributed among these fibers. Simultaneously, dialysis fluid, known as dialysate, is introduced into the bottom of the cartridge, bathing the outside of the fibers. Across the semipermeable membrane,...
305
Factors Affecting the Risk of Infection01:26

Factors Affecting the Risk of Infection

The hosts' susceptibility to infection depends on several factors. The integrity of the skin and mucous membranes helps protect the body against microbial attacks. When the skin is altered, the chance of infection, limb loss, and even death increases.
The integrity and count of the white blood cells help the body resist pathogens and fight infection. When impaired, it reduces the body's resistance to pathogens. The acidic pH levels of the gastrointestinal, genitourinary tracts, and skin...
13.0K
Multiple Allele Traits01:49

Multiple Allele Traits

The Concept of Multiple Allelism
36.8K
Pharmacokinetics in Pediatric Patients: Drug Excretion01:26

Pharmacokinetics in Pediatric Patients: Drug Excretion

In pediatric medicine, understanding the renal function and drug elimination nuances is crucial for administering safe and effective treatments. Newborns, in particular, display markedly slower renal functions than adults, profoundly affecting how drugs are cleared from their bodies. This slower drug clearance requires clinicians to extend the dosing intervals for many medications to prevent drug accumulation and toxicity while ensuring therapeutic efficacy.One key area where these adjustments...
105
Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications01:25

Peritoneal Dialysis II: Peritoneal Dialysis Systems and Complications

Peritoneal dialysis (PD) is a medical process that removes waste products and excess fluid from the body using the peritoneal membrane as a natural filter.Peritoneal Dialysis MethodsSeveral methods can be used for peritoneal dialysis, including Acute Intermittent Peritoneal Dialysis, Continuous Ambulatory Peritoneal Dialysis, and Automated Peritoneal Dialysis, also known as Continuous Cyclic Peritoneal Dialysis.Acute Intermittent Peritoneal Dialysis (AIPD) is used for patients with uremic...
220
Pharmacokinetics in Pediatric Patients: Drug Distribution01:17

Pharmacokinetics in Pediatric Patients: Drug Distribution

Drug distribution in the pediatric population exhibits unique challenges and considerations due to the physiological differences between children, particularly neonates and infants, and adults. A crucial aspect of pediatric pharmacology is understanding how these differences impact the pharmacokinetics of various drugs, necessitating age-specific dosing strategies to ensure efficacy and safety.Neonates and infants have a higher total body water content, ~75%–90% of their body weight,...
127